ArticleThe lancet. Gastroenterology & hepatology2020
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.
Article in The lancet. Gastroenterology & hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04375670 (COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
COVID19-FOIE National Observatory. An Ambispective Cohort Study of All Consecutive Patients
Who cites it
37 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.Journal of clinical gastroenterology · 2021Guideline
- Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.Singapore medical journal · 2020Guideline
- Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.Clinics and research in hepatology and gastroenterology · 2020Guideline
- COVID-19: gastrointestinal and hepatobiliary manifestations.Human pathology · 2023Review
- Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.World journal of gastroenterology · 2023Review
- Elucidating the role of environmental management of forests, air quality, solid waste and wastewater on the dissemination of SARS-CoV-2.Hygiene and environmental health advances · 2022Review
- Patterns of liver profile disturbance in patients with COVID-19.World journal of clinical cases · 2022Review
- Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database.Journal of Korean medical science · 2022Article
- From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.Internal and emergency medicine · 2022Review
- High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.Virulence · 2021Article
- Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.World journal of gastroenterology · 2021Review
- Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives.World journal of clinical cases · 2021Review
- Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region.Clinics and research in hepatology and gastroenterology · 2021Observational
- Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021Review
- Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms.World journal of gastroenterology · 2021Review
- Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations.Transplantation proceedings · 2020Article
- Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports.World journal of hepatology · 2020Article
- Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics.Molecular neurobiology · 2020Review
- SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.Biochimica et biophysica acta. Molecular basis of disease · 2020Review
- Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020Review
Corrections and comments
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.